The effect of ticagrelor based dual antiplatelet therapy on development of late left ventricular thrombus after acute anterior ST elevation myocardial infarction
International Journal of Cardiology, cilt.287, ss.19-26, 2019 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 287
- Basım Tarihi: 2019
- Doi Numarası: 10.1016/j.ijcard.2019.04.010
- Dergi Adı: International Journal of Cardiology
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.19-26
- Anahtar Kelimeler: Anterior ST elevation myocardial infarction, Clopidogrel, Dual antiplatelet therapy, Left ventricular thrombus, Ticagrelor
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
Aim: The aim of this study is to investigate the impact of ticagrelor as compared to clopidogrel based dual antiplatelet therapy (DAPT)during post-discharge management on the incidence of left ventricular (LV)thrombus in patients with first acute anterior ST elevation myocardial infarction (STEMI). Method: 641 patients who met the inclusion criteria were divided into two groups based on the receipt of either ticagrelor or clopidogrel based DAPT. Result: Left ventricular thrombus was detected in 73 (11.4%)patients at the first month echocardiographic examination. Ticagrelor based DAPT was associated with significantly less incidence of LV thrombus when compared to clopidogrel [20 (7.4%)vs 53 (14.0%)OR: 0.50 (0.29–0.86)]. Penalized maximum likelihood estimation (PMLE)logistic regression analyses were performed to fourteen candidate variables for identifying the independent predictors of LV thrombus, ticagrelor (compared with clopidogrel)[OR: 0.53 (0.28–0.96), p = 0.039], body mass index (BMI)[OR: 0.58 (0.44–0.77), p < 0.001], KILLIP class (I vs II–IV)[OR: 0.35 (0.14–0.83), p = 0.017], age [OR: 1.22 (1.08–1.40), p < 0.001], poor postprocedural myocardial blush grade (MBG)[OR: 3.35 (1.32–8.15), p = 0.012]and LVEF predischarge [OR: 0.79 (0.72–0.86), p < 0.001]were found to be associated with LV thrombus. Conclusion: Our study demonstrated that the incidence of LV trombus was significantly lower with ticagrelor than clopidogrel-based DAPT during postdischarge treatment for anterior STEMI patients.